Jonathan Yong
Stock Analyst at UBS
(2.61)
# 2,233
Out of 4,981 analysts
97
Total ratings
60.38%
Success rate
11.15%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHTH eHealth | Maintains: Neutral | $7 → $5 | $3.92 | +27.55% | 6 | Aug 7, 2025 | |
| CLOV Clover Health Investments | Maintains: Neutral | $4.5 → $3 | $3.14 | -4.46% | 4 | Aug 6, 2025 | |
| OSCR Oscar Health | Downgrades: Sell | $15 → $11 | $18.73 | -41.27% | 8 | Jul 15, 2025 | |
| PINC Premier | Maintains: Neutral | $33 → $25 | $26.51 | -5.70% | 2 | Aug 24, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $7.70 | +55.84% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $4.08 | +96.08% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $13.16 | +97.57% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $53.96 | -74.05% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $68.81 | +39.51% | 3 | Aug 8, 2023 | |
| SEM Select Medical Holdings | Maintains: Neutral | $29 → $32 | $12.24 | +161.44% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $105 | $18.23 | +475.97% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $124.66 | -35.83% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $275.40 | -16.12% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $7.67 | +252.02% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $150.27 | -33.45% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $702.88 | -35.98% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $4.05 | +196.30% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $6.56 | +967.07% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $15.97 | +6.45% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $176.11 | +98.74% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $21.42 | +343.51% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $4.84 | +75.62% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $22.34 | +83.53% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $5.20 | +226.92% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $2.93 | +190.10% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $79.71 | +6.64% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $180.62 | -19.17% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $32.64 | +224.75% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $189.58 | -17.19% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $297.14 | +23.85% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $275.42 | +130.56% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $73.46 | +59.27% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $16.57 | +81.05% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $403.17 | -26.09% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $186.75 | -49.13% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $347.89 | +42.29% | 1 | Oct 15, 2021 |
eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $3.92
Upside: +27.55%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5 → $3
Current: $3.14
Upside: -4.46%
Oscar Health
Jul 15, 2025
Downgrades: Sell
Price Target: $15 → $11
Current: $18.73
Upside: -41.27%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $25
Current: $26.51
Upside: -5.70%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $7.70
Upside: +55.84%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $4.08
Upside: +96.08%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $13.16
Upside: +97.57%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $53.96
Upside: -74.05%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $68.81
Upside: +39.51%
Select Medical Holdings
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $12.24
Upside: +161.44%
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $18.23
Upside: +475.97%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $124.66
Upside: -35.83%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $275.40
Upside: -16.12%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $7.67
Upside: +252.02%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $150.27
Upside: -33.45%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $702.88
Upside: -35.98%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $4.05
Upside: +196.30%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $6.56
Upside: +967.07%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $15.97
Upside: +6.45%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $176.11
Upside: +98.74%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $21.42
Upside: +343.51%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $4.84
Upside: +75.62%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $22.34
Upside: +83.53%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $5.20
Upside: +226.92%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $2.93
Upside: +190.10%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $79.71
Upside: +6.64%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $180.62
Upside: -19.17%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $32.64
Upside: +224.75%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $189.58
Upside: -17.19%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $297.14
Upside: +23.85%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $275.42
Upside: +130.56%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $73.46
Upside: +59.27%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $16.57
Upside: +81.05%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $403.17
Upside: -26.09%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $186.75
Upside: -49.13%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $347.89
Upside: +42.29%